NCT01629589 Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents Status COMPLETED Phase PHASE4
NCT01545115 Study of the Environmental Factors Modulating Children Immune Response in Northern Senegal Status COMPLETED Phase N/A
NCT01529645 Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years Status COMPLETED Phase PHASE1
NCT01444781 Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants Status COMPLETED Phase PHASE3
NCT01439165 Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose Status COMPLETED Phase PHASE4
NCT01177722 A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants Status COMPLETED Phase PHASE3
NCT01105559 Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine Status COMPLETED Phase N/A
NCT00662870 Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine Status COMPLETED Phase PHASE3
NCT00337428 Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00325130 Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025) Status COMPLETED Phase PHASE3
NCT00004422 Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection Status COMPLETED Phase PHASE3